As functional skincare ingredients continue to evolve toward greater precision and performance, synthetic peptides have become a core category in advanced product development due to their design flexibility and structural stability. With expanding application scenarios, synthetic peptides have developed into a multi-dimensional classification system. For procurement professionals, a clear understanding of these types is essential for efficient ingredient selection and building differentiated product portfolios.
From a functional and application perspective, synthetic peptides can be broadly categorized as follows
First, signal peptides. These peptides work by delivering biological signals to skin cells, stimulating the production of collagen and elastin. They are widely used in anti-aging and firming formulations.
Second, carrier peptides. These peptides bind with trace elements or metal ions and facilitate their delivery into deeper layers of the skin, supporting enzymatic activity and tissue repair processes. They are commonly used in restorative and strengthening products.
Third, neurotransmitter-modulating peptides. This category regulates neuromuscular signaling, helping to reduce muscle contractions that lead to expression lines. They are highly востребованы in wrinkle-reduction formulations.
In addition, enzyme-inhibiting peptides play an important role by slowing down enzymatic processes associated with skin aging, thereby helping to preserve collagen and maintain skin structure. These are often used in preventive anti-aging products.
In practical applications, multi-functional or blended peptides are gaining increasing attention. By combining different peptide types, they enable synergistic effects across anti-aging, repair, and barrier enhancement functions.
From a procurement standpoint, different peptide categories correspond to varying levels of technical complexity and application positioning. Single-function products tend to emphasize cost efficiency and supply stability, while advanced or multifunctional peptides rely more heavily on R&D capability and efficacy validation. Suppliers with the ability to develop multiple peptide types generally hold a stronger competitive advantage.
Overall, the diversification of synthetic peptide types provides more flexible formulation strategies and supports the industry's transition from single-function ingredients to integrated, solution-oriented approaches.
